Does DARBEPOETIN ALFA Cause Embolism? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Embolism have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.0% of all adverse event reports for DARBEPOETIN ALFA.
14
Reports of Embolism with DARBEPOETIN ALFA
0.0%
of all DARBEPOETIN ALFA reports
13
Deaths
6
Hospitalizations
How Dangerous Is Embolism From DARBEPOETIN ALFA?
Of the 14 reports, 13 (92.9%) resulted in death, 6 (42.9%) required hospitalization.
Is Embolism Listed in the Official Label?
Yes, Embolism is listed as a known adverse reaction in the official FDA drug label for DARBEPOETIN ALFA.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Hospitalisation (5,682)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
What Other Drugs Cause Embolism?
BEVACIZUMAB (378)
PACLITAXEL (251)
LENALIDOMIDE (206)
DEXAMETHASONE (204)
RITUXIMAB (204)
CYCLOPHOSPHAMIDE (202)
DOXORUBICIN (198)
RIVAROXABAN (197)
CARBOPLATIN (187)
APIXABAN (181)
Which DARBEPOETIN ALFA Alternatives Have Lower Embolism Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE